Key Pharmaceutical Executive Joins Mesoblast NEW YORK and MELBOURNE, Australia, March 10, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that Jonathan R. Symonds, CBE, the former...